INTREPId (INTermediate Risk Erection PreservatIon Trial): A randomized trial of radiation therapy and darolutamide for prostate cancer

被引:0
|
作者
King, Martin T.
Wise, David R.
Scala, Lawrence M.
Mariados, Neil M.
Whitbeck, Amanda
Pomerantz, Mark
Bober, Sharon
Davicioni, Elai
Bubley, Glenn
Nguyen, Paul L.
机构
[1] Brigham & Womens Hosp, Dana Farber Canc Inst, 75 Francis St, Boston, MA 02115 USA
[2] NYU, Med Ctr, New York, NY 10016 USA
[3] Kaiser Permanente, Santa Clara, CA USA
[4] Associated Med Profess New York PLLC, Syracuse, NY USA
[5] Dana Farber Canc Inst, Boston, MA 02115 USA
[6] Dana Farber Canc Inst, Lank Ctr Genitourinary Oncol, Boston, MA 02115 USA
[7] GenomeDx Biosci Inc, Vancouver, BC, Canada
[8] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[9] Harvard Med Sch, Brigham & Womens Hosp, Dana Farber Canc Inst, Boston, MA 02115 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
TPS384
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Randomized phase II trial of IGRT with or without HDR boost in intermediate-risk prostate cancer
    Vigneault, E.
    Morton, G.
    Perulekar, W.
    Niazi, T.
    Springer, G.
    Barkati, M.
    Chung, P.
    Koll, W.
    Kamran, A.
    Montreal, M.
    Ding, K.
    Loblaw, A.
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S975 - S976
  • [22] Androgen suppression and radiation vs radiation alone for prostate cancer - A randomized trial
    D'Amico, Anthony V.
    Chen, Ming-Hui
    Renshaw, Andrew A.
    Loffredo, Marian
    Kantoff, Philip W.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 299 (03): : 289 - 295
  • [23] Survival and Larynx Preservation in Early Glottic Cancer: A Randomized Trial Comparing Laser Surgery and Radiation Therapy
    Pakkanen, Pihla
    Irjala, Heikki
    Ilmarinen, Taru
    Halme, Elina
    Lindholm, Paula
    Makitie, Antti
    Wigren, Tuija
    Aaltonen, Leena-Maija
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 113 (01): : 96 - 100
  • [24] Effect of Standard vs Dose-Escalated Radiation Therapy for Patients With Intermediate-Risk Prostate Cancer The NRG Oncology RTOG 0126 Randomized Clinical Trial
    Michalski, Jeff M.
    Moughan, Jennifer
    Purdy, James
    Bosch, Walter
    Bruner, Deborah W.
    Bahary, Jean-Paul
    Lau, Harold
    Duclos, Marie
    Parliament, Matthew
    Morton, Gerard
    Hamstra, Daniel
    Seider, Michael
    Lock, Michael I.
    Patel, Malti
    Gay, Hiram
    Vigneault, Eric
    Winter, Kathryn
    Sandler, Howard
    JAMA ONCOLOGY, 2018, 4 (06)
  • [25] Effect of Brachytherapy With External Beam Radiation Therapy Versus Brachytherapy Alone for Intermediate-Risk Prostate Cancer: NRG Oncology RTOG 0232 Randomized Clinical Trial
    Michalski, Jeff M.
    Winter, Kathryn A.
    Prestidge, Bradley R.
    Sanda, Martin G.
    Amin, Mahul
    Bice, William S.
    Gay, Hiram A.
    Ibbott, Geoffrey S.
    Crook, Juanita M.
    Catton, Charles N.
    Raben, Adam
    Bosch, Walter
    Beyer, David C.
    Frank, Steven J.
    Papagikos, Michael A.
    Rosenthal, Seth A.
    Barthold, H. Joseph
    Roach, Mack
    Moughan, Jennifer
    Sandler, Howard M.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (24) : 4035 - +
  • [26] Radiation Therapy Deviations in Trial of Locally Advanced Prostate Cancer
    Jani, Ashish
    Horowitz, David P.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 316 (13): : 1409 - 1410
  • [27] Re: Prospective Randomized Phase 2 Trial of Intensity Modulated Radiation Therapy with or without Oncolytic Adenovirus-Mediated Cytotoxic Gene Therapy in Intermediate-Risk Prostate Cancer
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2015, 193 (03): : 847 - 847
  • [28] Radiation therapy for intermediate risk prostate cancer: Dose escalation or hormonal therapy?
    Hannoun-Levi, J.
    Salem, N.
    Azria, D.
    Chamorey, E.
    Ginot, A.
    Moro, M.
    Cowen, D.
    Teissier, E.
    Ellis, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S379 - S379
  • [29] Risk of prostate cancer in a randomized clinical trial of calcium supplementation
    Baron, JA
    Beach, M
    Wallace, K
    Grau, MV
    Sandler, RS
    Mandel, JS
    Heber, D
    Greenberg, ER
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (03) : 586 - 589
  • [30] Radiotherapy with or without short term androgen deprivation therapy in intermediate risk prostate cancer: final results of a phase III randomized trial
    Nabid, Abdenour
    Carrier, Nathalie
    Vigneault, Eric
    Thu Van Nguyen
    Vavassis, Peter
    Brassard, Marc-Andre
    Bahoric, Boris
    Archambault, Robert
    Vincent, Francois
    Bettahar, Redouane
    Wilke, Derek
    Souhami, Luis
    SCANDINAVIAN JOURNAL OF UROLOGY, 2019, 53 : 8 - 8